Peter Voorhees, MD, explains how daratumumab and hyaluronidase-fihj show superior efficacy in delaying progression of MM ...

This was not the first presentation on STI-571, but it was the one that would change everything: The New England Journal of ...

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions ...

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions ...

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions ...

CKM syndrome, which links heart disease, kidney disease, diabetes, and obesity, is a fairly new concept. As a result, ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting ...

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community ...

Overall, 98,150 procedures (32%) met criteria for low-value care. Among these, 54,553 (56%) occurred between 2016 and 2019 ...

The CAR T Vision Steering Committee has set an ambitious goal: to double the proportion of eligible patients treated with CAR T by 2030. 2 Reimbursement challenges stand out as an area where ...

With ACA subsidies ending in 2025, Ben Light explains how rising premiums may push individuals toward ICHRAs and reshape employer health coverage strategy.

“Olomorasib, in combination with pembrolizumab, has demonstrated significant efficacy and a manageable safety profile in patients with KRAS G12C-mutant advanced/metastatic NSCLC, including patients ...